Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis

Neutrophil activation was the key feature in active sJIA. The three molecular subtype scheme enables the formulation of precision medicine strategies in sJIA.

Authors

Institutions

Publication Details

Journal
Arthritis Research & Therapy
Published
2025-02-08
DOI
https://doi.org/10.1186/s13075-025-03498-8
Citations
7
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
12.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis

Jung Woo Rhim, Ki‐Jo Kim, Kyungsu Park, In‐Woon Baek
7 citations
Arthritis Research & Therapy
Autoimmune and Inflammatory Disorders Research
12.39
article

Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis

Jung Woo Rhim, Ki‐Jo Kim, Kyungsu Park, In‐Woon Baek
article en
7 citations

Abstract

Neutrophil activation was the key feature in active sJIA. The three molecular subtype scheme enables the formulation of precision medicine strategies in sJIA.

Arthritis Research & TherapyVol. 27(1)
Ewha Womans University (KR), The Catholic University of Korea St. Vincent's Hospital (KR), The Catholic University of Korea Daejeon St. Mary's Hospital (KR), Catholic University of Korea (KR)
Good health and well-being
Openalex Percentile: Top 1%
Autoimmune and Inflammatory Disorders Research
12.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.